No emergency use approval for Bharat Biotech's Covaxin in
Published : 2021-06-12 - Duration : 04:11 - View : 7
Dailymotion : Download MP4 Convert to MP3
Description :
The US Food and Drug Administration (FDA) has rejected Bharat Biotech’s proposal for an emergency use authorization (EUA) of its Covid-19 vaccine, delaying the company’s vaccine launch in that country. Ocugen, the US partner of Bharat Biotech, on Thursday said the company will now be seeking a full approval of Covaxin. This is a consequence of ...
Related Videos :
Bharat Biotech seeks emergency use approval for Covid-19 vaccine Covaxin | Oneindia News Created : 08-12-2020 View : 476 |
Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News Created : 03-11-2021 View : 1,071 |
Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources Created : 02-01-2021 View : 2 |
US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin Created : 11-06-2021 View : 15 |
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI Created : 04-01-2021 View : 3 |